Welcome to Coulter Partners Global (English)

20 October 2022

Top hires for VC & PE portfolio companies Q3-2022

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
Chief Commercial Officer Rapid molecular diagnostics Belgium
Chief Medical Officer Radiopharmaceuticals China
Chief Medical Officer Oncology biotech US
Country Chief Financial Officer In/outpatient services Austria
Chief R&D Officer Small molecule therapeutics UK
Chief Communications Officer Medical research charity UK
SVP Head of Global Clinical Operations Immuno-oncology biotech US
VP Intellectual Property Protein degradation technology UK
VP Marketing Big data discovery Belgium
Head of Clinical Operations Anticoagulant development Netherlands
Head of Biology Radiotherapeutics Germany
VP Telehealth Ophthalmic technologies France
Director Central & Eastern Europe Drug delivery devices Ireland
Innovation Project Lead, Biomarker AI / cloud-enabled devices France

Newly opened projects include:

Function Focus area Location
CEO Cell therapies Switzerland
CEO Stem cell technologies UK
Chief Business Officer (US) Regenerative medicine France
Chief Medical Officer Genomic medicine US
Chief Scientific Officer Oncology biotech Switzerland
Chief Development Officer Cancer immunotherapies Singapore
Chief Financial Officer Infectious diseases US
Head of Business Development Small molecule therapeutics UK
VP CMC Gene therapy US
Country Manager x2 Digital patient services Nordics
Partner, Digital Health Investments Life sciences investor Italy
Board Director x2 Not-for-profit UK
Board Director Oncology immunotherapies France
Board Director Medical devices UK


A new version of Coulter Partners is available.